Incidence and influencing factors of olfactory dysfunction in patients 1 week after endoscopic transsphenoidal resection of pituitary tumor: a cross-sectional study of 158 patients

Autor: Sumei Zhou, Zhi Zeng, Min Chen, Linbo Zou, Shirong Shao

Publikováno v: Frontiers in Neurology, Vol 15 (2024)

ObjectiveTo investigate the current situation of olfactory dysfunction in patients after endoscopic transsphenoidal resection of pituitary tumors, and analyze its influencing factors, to provide references for clinical nursing and rehabilitation.Meth

Externí odkaz: https://doaj.org/article/adab3fa892e547359b17259ba91d48f7

Rathke’s Cleft Cyst Abscess—An Unusual Guest in The Sella

Autor: Piyush Lodha, P Rao Srinivas, Vijay Sheker Reddy Danda, Gollapudi Prakash Rao

Publikováno v: Indian Journal of Neurosurgery, Vol 11, Iss 01, Pp 073-075 (2022)

Abscess formation within a Rathke's cleft cyst (RCC) is extremely rare, particularly at a young age. We report the case of a young girl with abscess formation in RCC. A 21-year-old female presented with headache, vomiting, visual deterioration and fe

Externí odkaz: https://doaj.org/article/5023e09516fd47769b5b6d156836c840

Rathke’s Cleft Cyst Abscess—An Unusual Guest in The Sella

Autor: Piyush Lodha, Srinivas Rao P, Gollapudi Prakash Rao, Vijay Sheker Reddy Danda

Publikováno v: Indian Journal of Neurosurgery (2021)

Abscess formation within a Rathke's cleft cyst (RCC) is extremely rare, particularly at a young age. We report the case of a young girl with abscess formation in RCC. A 21-year-old female presented with headache, vomiting, visual deterioration and fe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bda8c1ce990b621580f6775300b1b40c
https://doi.org/10.1055/s-0041-1726600

The PRolaCT studies — a study protocol for a combined randomised clinical trial and observational cohort study design in prolactinoma

Autor: Zandbergen, I.M., Najafabadi, A.H.Z., Pelsma, I.C.M., Akker-van Marle, M.E. van den, Bisschop, P.H.L.T., Boogaarts, H.D.J., Bon, A.C. van, Burhani, B., Cessie, S. le, Dekkers, O.M., Drent, M.L., Feelders, R.A., Graaf, J.P. de, Hoogmoed, J., Kapiteijn, K.K., Klauw, M.M. van der, Nieuwlaat, W.A.C.M., Pereira, A.M., Stades, A.M.E., Ven, A.C. van de, Wakelkamp, I.M.M.J., Furth, W.R. van, Biermasz, N.R., Dutch Prolactinoma Study Grp

Publikováno v: Trials, 22(1):653. BioMed Central Ltd.
Trials, 22, 1
Trials, 22(1):653. BioMed Central
Trials, 22
Trials
on behalf of the Dutch Prolactinoma Study Group 2021, ' The PRolaCT studies — a study protocol for a combined randomised clinical trial and observational cohort study design in prolactinoma ', Trials, vol. 22, no. 1, 653 . https://doi.org/10.1186/s13063-021-05604-y
Trials, Vol 22, Iss 1, Pp 1-13 (2021)
Trials, 22(1). BMC

Background First-line treatment for prolactinomas is a medical treatment with dopamine agonists (DAs), which effectively control hyperprolactinaemia in most patients, although post-withdrawal remission rates are approximately 34%. Therefore, many pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb25cf2e5c5e1813c807c1e0b72c6a45
http://www.scopus.com/inward/record.url?scp=85115842154&partnerID=8YFLogxK

The PRolaCT studies - a study protocol for a combined randomised clinical trial and observational cohort study design in prolactinoma

Publikováno v: Trials. 22(1)

Background: First-line treatment for prolactinomas is a medical treatment with dopamine agonists (DAs), which effectively control hyperprolactinaemia in most patients, although post-withdrawal remission rates are approximately 34%. Therefore, many pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dris___01423::124b1a8e640b9e95043cacff96e1c3a6
https://doi.org/10.1186/s13063-021-05604-y